Linnaeus Therapeutics is engaged in the identification and development of small molecule agents that modulate melanocyte differentiation and pigmentation.
There is an urgent need for safe and effective treatment options for modifying melanin production for therapeutic benefit including:
- Preventing and treating melanoma
- Increasing or decreasing pigmentation to correct genetic and acquired skin conditions
- Aesthetically desirable skin tanning or skin lightening
Read More: About Us